CURRCULUM VITAE

Prof. Dr. Esin AKI-YALÇIN

Professor at the Pharmaceutical Chemistry Department of Faculty of Pharmacy, Ankara University

E-mail: esinaki@ankara.edu.tr

Tel: +90-532-3373111

Fax: +90-312-236940

GSM: +90-532-3373111

Affiliation: 1993- Full Professor at the Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ankara University

Background :

2018-2020 Elected President of Asian Federation of Medicinal Chemistry 2009-2012 Rector Consultant of Ankara University 2008-2009 Dean of Faculty of Pharmacy, Ankara University 2003-2006 Chair of Pharmaceutical Sciences Division, Faculty of Pharmacy, Ankara University 1999-2002 Chair of Pharmaceutical Chemistry Department Faculty of Pharmacy, Ankara University 1993 Professor Degree Pharmaceutical Chemistry Dept., Faculty of Pharmacy, Ankara University. 1987 Assoc. Prof. Degree Pharmaceutical Chemistry Dept., Faculty of Pharmacy, Ankara University. 1986 Assist. Prof. Degree Pharmaceutical Chemistry Dept., Faculty of Pharmacy, Ankara University. 1983 Ph. D. Degree Pharmaceutical Chemistry Dept., Faculty of Pharmacy, Ankara University.

Member of International Organisations: 2004- : “International QSAR and Chemoinformatics” Member of Chairs’ Board 2004-2009 : “International QSAR and Chemoinformatics” Executive Committee member 2006-2008 : “Asian Federation of Medicinal Chemistry “ Executive

Committee member, General Secretary

2004- : Establisher and President of Computer Aided Drug Design and Development Society in Turkey Chair of Organization Committee of International Meetings;

1. 15th European Symposium on Quantitative Structure-Activity Relationships”, İstanbul, Turkey, 05-10 September 2004. Chair of Organisation Committee.

2. 6th AFMC Medicinal Chemistry Symposium, Istanbul, Turkey, 08-11 July 2007. Chair of Organisation Committee.

3. 5th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources”, 04-08 July 2009, Istanbul, Turkey. Chair of Organisation Committee.

Chair of Organization of National Meetings;

1. Workshop on Computer Aided Drug Design & Development, 02-05 Feb 2007, Istanbul, Turkey. Chair of Organisation Committee.

2. Workshop on Computer Aided Drug Design & Development-Molecular Modelling, 26-29 June 2008Ankara, Turkey. Chair of Organisation Committee.

Awards: 1.International Scientific Partnership Foundation Medal “Badge of Honor" 2. International Scientific Partnership Foundation Honourable Diploma of ISPF.

3. “Asian Federation of Medicinal Chemistry” Lifetime Fellowship Diploma.

Research subjects: Synthesis and chemotherapeutical activity studies of novel heterocyclic compounds. Computational Drug Design Methods; Quantitative Structure-Activity Relationships, Molecular Modelling Techniques.

1

PUBLICATIONS of Prof. Dr. ESIN AKI YALÇIN (ŞENER) A- ORIGINAL PAPERS A. 1. INTERNATIONAL A.1.1. SCI - SCI Expanded Journals: [1] YALCIN, I., SENER, E., OZDEN, T., OZDEN, S., AKIN, A., Synthesis and

Microbiological Activity of 5-Metyl-2-(p-substituted-phenyl)benzoxazoles, European Journal of Medicinal Chemistry, 25, 705-708 (1990).

[2] SENER. E., YALCIN, I., SUNGUR, E., QSAR of Some Antifungal Benzoxazoles and Oxazolo (4,5-b)pyridines Against C. albicans, Quantitative Structure-Activity Relationships, 10, 223-228 (1991).

[3] YALCIN, I., OREN, I., SENER, E., AKIN, A., UCARTURK, N., The Synthesis and the Structure- Activity Relationships of Some Substituted Benzoxazoles, Oxazolo(4,5-b)pyridines, Benzothiazoles and Benzimidazoles as Antimicrobial Agents, European Journal of Medicinal Chemistry, 27, 401-406 (1992).

[4] YALCIN, I., SENER, E., QSARs of Some Novel Antibacterial Benzimidazoles, Benzoxazoles and Oxazolopyridines Against an Enteric Gram-negative Rod, International Journal of Pharmaceutics, 98, 1-8 (1993).

[5] SENER, E., TURGUT,H., YALCIN, I., OREN, I., TURKER, L., CELEBI, N., AKIN, A., Structure-Activity Relationships of Some Antimicrobial 5-Substituted-2-(3-pyridyl)benzoxazoles Using Quantum Chemical Calculations, International Journal of Pharmaceutics, 110, 109-115 (1994).

[6] SENER, E., YALCIN, I., TEMIZ, O., OREN, I., AKIN, A. AND UCARTURK, N. “Synthesis and Structure-Activity Relationships of Some 2,5-Disubstitured Benzoxazoles and Benzimidazoles as Antimicrobial Agents”, Il Farmaco, 52(2), 99-103 (1997).

[7] OREN, I., TEMIZ, O., YALCIN, I., SENER, E., AKIN, A., UCARTURK, N. “Synthesis and Microbiological Activity of 5(or 6)-Methyl-2-substituted Benzoxazole and Benzimidazole Derivatives”, Arzneim-Forsch./Drug Res., 47(12), 1393-1397 (1997).

[8] YALCIN, I., KAYMAKCIOGLU, B. K., OREN, I., SENER, E., TEMIZ, O., AKIN, A., ALTANLAR, N., “Synthesis and Microbiological Activity of Some Novel N-(2-Hydroxyl-5-substitutedphenyl)benzacetamides, Phenoxyacetamides and Thiophenoxyacetamides as The Possible Metabolites of Antimicrobial Active Benzoxazoles”, Il Farmaco, 52(11), 685-689 (1997).

[9] TEMIZ, O., OREN, I., SENER, E., YALCIN, I., UCARTURK, N., “Synthesis and Microbiological Activity of Some Novel 5- or 6-Methyl-2-(2,4-disubstituted phenyl)benzoxazole Derivatives”, Il Farmaco, 53, 337-341 (1998).

[10] OREN, I., TEMIZ, O., YALCIN, I., SENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2, 5- and/or 6-Substituted Benzoxazole and Benzimidazole Derivatives”, European Journal of Pharmaceutical Sciences, 7, 153-160 (1998).

2

[11] MROZEK, A., KAROLAK-WOICIECHOWSKA, J., YALCIN, I., SENER, E., “Crystal Structure of 2-(2-Cyclohexyl)ethyl benzimidazole”, Z. Kristallogr. NCS, 214, 181-182 (1999).

[12] MROZEK, A., TRZEZWINSKA, H., KAROLAK-WOICIECHOWSKA, J., YALCIN I., SENER, E., “Molecular Structure of 5-Chloro-2-(p-t-butylphenyl)benzoxazole. Relation Between Structure and Antimicrobial Activity of 2,5-Disubstituted Benzoxazoles”, Polish J. Chem., 73, 625-633 (1999).

[13] AKI-SENER, E., ARPACI-TEMIZ, O., YALCIN, I., ALTANLAR, N.; “Synthesis and microbiological activity of some novel 5-benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole derivatives” Il Farmaco, 55, 397-405 (2000) .

[14] YALCIN, I., OREN, I., TEMIZ, O., AKI-SENER, E., “QSARs of some novel isosteric heterocyclics with antifungal activity” Acta Biochimica Polonica, 47 (2), 481-486 (2000).

[15] AKI-SENER, E., BINGOL, K.K., OREN, I., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N.: “Synthesis and microbiological activity of some N-(o-hydroxyphenylbenzmides and phenylacetamides as the possible metabolites of antimicrobial active benzoxazoles, Part II.”, Il Farmaco, 55, 469-476 (2000).

[16] R. CZYLKOWSKI, J. KAROLAK-WOJCIECHOWSKA, YALCIN, I., AKI-SENER, E., “Structure and Conformational Preferences of 2-Substituted-benzoxazoles”, J. Mol. Structure, 598(2-3), 197-205, 2001

[17] AKI-SENER, E., BINGOL, K.K., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N, “Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible metabolites of antimicrobial active benzoxazoles”, Il Farmaco, 57, 451-456, (2002).

[18] TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I., ALTANLAR, N., “Synthesis and microbiological activity of some novel N-[2-(p-substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, -cyclohexyl acetamide and –cyclohexyl propionamide derivatives”, Il Farmaco, 57, 771-775, (2002).

[19] TEMİZ-ARPACI, Ö., AKI-ŞENER E., YALÇIN, İ., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2-(p-substituted-phenyl)benzoxazol-5-yl-arylcarboxamides”, Arch. Pharm. Pharm. Med. Chem, 6, 283-288, (2002).

[20] AKBAY, A., OREN, I., TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I., “Synthesis and HIV-1 Reverse Transcriptase Inhibitor Activity of Some 2,5,6-Substituted Benzoxazole, Benzimidazole, Benzothiazole and Oxazolo(4,5-b)pyridine Derivatives”, Arzneim-Forsch./Drug Res., 53 (4), 266-271, (2003).

[21] YALCIN, I., TEKINER; B. P., OREN-YILDIZ, I., TEMIZ-ARPACI, O., AKI-SENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2,6,7-trisubstituted-2H-3,4-dihydro-1,4-benzoxazin-3-one Derivatives”, Indian Journal of Chemistry, 42B, 905-909, (2003).

[22] ALPER, S., TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I.,”Some New bi-and ter-benzimidazole Derivatives as Topoisomerase I Inhibitors”, Il Farmaco, 58, 497-507, (2003).

[23] YILDIZ-OREN, I., AKI-SENER, E., ERTAS, C., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N., “Synthesis and Microbiological activity of Some Substituted N-(2-hydroxy-4-nitrophenyl)benzamides, henylacetamides as Possible Metabolites of Antimicrobial Active Benzoxazoles”, Turk J Chem., 28, 441-449, (2004).

3

[24] PINAR, A., YURDAKUL, P., YILDIZ, I., TEMIZ-ARPACI, O., ACAN, N.L.,

AKI-SENER, E., YALCIN, İ.,”Some Fused Heterocyclic Compounds as Eukaryotic Topoisomerase II Inhibitors”, Biochemical and Biophysical Research Communications, 317, 670-674, (2004).

[25] OREN-YILDIZ, I., YALCIN, I., AKI-SENER E., ALTANLAR, N., “Synthesis and Structure-Activity Relationships of New Antimicrobial Active Multisubstituted Benzoxazole Derivatives”, European Journal of Medicinal Chemistry, 39, 291-298, (2004).

[26] PLEMPER, R.K., ERLANDSON, K.J., LAKDAWALA, A.S., SUN, A., PRUSSIA, A., BOONSOMBAT, J., AKI-SENER E., YALÇIN, I., YILDIZ, I., TEMIZ-ARPACI, O., TEKINER; B. P., LIOTTA, D., SNYDER, J.P., COMPANS, R.W., “A Target Site for Template-Based Design of Measles Virus Entry Inhibitors”, PNAS, 101(15), 5628-5633, (2004).

[27] OREN-YILDIZ, I., TEKINER-GULBAS, B. P., YALCIN, I., TEMIZ-ARPACI, O., AKI-SENER E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of New 2-[p-Substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles”, Arch. Pharm. Pharm. Med. Chem, 337, 402-410, (2004).

[28] TEMIZ-ARPACI, O., OZDEMIR, A., YALCIN, I., YILDIZ, I., AKI-SENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 5-[2-(Morpholin-4-yl)acetamido] and/or 5-[2-(4-Substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles”Arch. Pharm. Chem. Life Sci. 338, 105-111 (2005).

[29] TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method” Bioorganic and Medicinal Chemistry, 13, 6354-6359, 2005.

[30] TEMIZ-ARPACI, O., OZDEMIR, A., YALCIN, I., YILDIZ, I., AKI-SENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 5-[2-(Morpholin-4-yl)acetamido] and/or 5-[2-(4-Substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles, Arch. Pharm. Chem. Life Sci., 338, 105-111, (2005).

[31] TEMIZ-ARPACI, O, TEKINER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular .field analysis method” Bioorganic & Medicinal Chemistry, (2005), 13, 6354–6359.

[32] VARGA, A., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., CHEREPNEV, G., MOLNAR, J., “Induction of Apoptosis and Necrosis by Resistance Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 Mdr+cells” In vivo, 19, 1087-1092, (2005).

[33] LAGE, H., TEKINER-GULBAS, B., TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I., “High antineoplastic activity of heterocyclic DNA topoisomerase II inhibitors in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs and structure-activity relationships”, Int. J. Cancer., 119, 213-220, 2006.

4

[34] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3-D-QSAR Study on Heterocyclic Topoisomerase II Inhibitors Using CoMSIA”, SAR and QSAR in Enviromental Research, 17(2), 1-12, 2006.

[35] TEMIZ-ARPACI, O., COBAN, T., TEKINER-GULBAS, B., CAN-EKE, B., YILDIZ, İ., AKI-SENER, E., YALCIN, I., ISCAN, M., “A Study on the Antioxidant Activties of Some New Benzazole Derivatives”, Acta Biol. Hungarica, 57 (2), 201-209, 2006.

[36] ALPER-HAYTA, S., AKI-SENER, E., TEKINER-GULBAS, B., YILDIZ, İ., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N., “Synthesis, Antimicrobial Activity and QSARs of New Benzoxazine-3-ones”, Eur. J. Med. Chem., 41, 1398-1404, 2006.

[37] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3D-QSAR Study on Heterocyclic Topoisomerase II Inhibitors using CoMSIA”, SAR and QSAR in Enviromental Research, 17(2), 121-132, (2006).

[38] ERTAN, T., YILDIZ, I., OZKAN, S., TEMIZ-ARPACI, O., KAYNAK, F., YALCIN, I., AKI-SENER, E., ABBASOGLU, U., "Synthesis and Biological Evaluation of New n-(2-Hydroxy-4(or 5)-nitro/ aminophenyl)benzamides and Phenylacetamides as Antimicrobial Agents", Bioorganic and Medicinal Chemistry, 15, 2032-2044, (2007).

[39] KAROLAK-WOJCIECHOWSKA, J., MROZEK, A., CZYLKOWSKI, R., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Five-membered heterocycles. Part IV: Impact of heteroatom on benzazole aromaticity", Journal of Molecular Structure, 839, 125-131, (2007).

[40] OKSUZOGLU, E., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., EROGLU, H., SEN, G., ALPER, S., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "A Study on the Genotoxic Activities of Some New Benzoxazoles", Medicinal Chemistry Research, 16, 1–14, (2007)

[41] OKSUZOGLU, E., TEKINER-GULBAS, B., ALPER, S., TEMIZ-ARPACI, O., ERTAN, T., YILDIZ, I., DIRIL, N., SENER-AKI, E., YALCIN, I., "Some Benzoxazoles and Benzimidazoles as DNA Topoisomerase I and II Inhibitors", Journal of Enzyme Inhibition and Medicinal Chemistry, 23, 37-42, (2007).

[42] TEKINER-GULBAS, B., TEMIZ-ARPACI, O., OKSUZOGLU, E., EROGLU, H., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "QSAR of Genotoxic Active Benzazoles", SAR and QSAR in Environmental Research, 18, 251–263, (2007).

[43] MARTINS, M., SCHELZ, Z., MARTINS, A., MOLNAR, J., HAJÖS, G., RIEDL, Z., VIVEIROS, M., YALCIN, I., AKI-SENER, E., AMARAL, L., "In Vitro and Ex Vivo Activity of Thioridazine Derivatives against Mycobacterium tuberculosis", International Journal of Antimicrobial Agents, 29, 338–340, (2007).

[44] YILDIZ, I., ERTAN, T., BOLELLI, K., TEMIZ-ARPACI, O.,YALCIN, I. AKI, E., "QSAR and Pharmacophore Analysis on Amides against Drug-Resistant S. aureus", SAR and QSAR in Environmental Research, 19, 101-113, (2008).

[45] ARISOY, M., TEMIZ-ARPACI, O., YILDIZ, I., KAYNAK-ONURDAG, F., AKI, E., YALCIN, I., ABBASOGLU, U., "Synthesis, Antimicrobial Activity and QSAR Studies of 2,5-Disubstituted Benzoxazoles", SAR and QSAR in Environmental Research, 19:5, 589-612, (2008).

5

[46] TEKINER-GULBAS, B., FILAK, L., VASKO, G.A., EGYED, O., YALÇIN, I., AKI-SENER, E., RIEDL, Z., HAJOS, G., "Synthesis of Novel Pyrazolo[5,1-b][1,3]benzothiazoles: a New Pericyclic Pathway", Heterocycles, 75, 2005-2012, (2008).

[47] TEMIZ-ARPACI, O.,YILDIZ, I., ÖZKAN, S., KAYNAK, F., AKI-ŞENER, E., YALÇIN, I., "Synthesis and Biological Activity of Some New Benzoxazoles", European Journal of Medicinal Chemistry, 43, 1423-1431, (2008).

[48] ALPER-HAYTA, S., ARISOY, M., TEMIZ-ARPACI, Ö., YILDIZ, I., AKI, E., ÖZKAN, S., KAYNAK, F., "Synthesis, Antimicrobial Activity, Pharmacophore Analysis of Some New 2-(Substitutedphenyl/ benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles", European Journal of Medicinal Chemistry, 43, 2568-2578, (2008).

[49] FILAK, L., TEKINER-GULBAS,B., RIEDL, Z., VASKÓ, G.A., EGYED,O., YALÇIN, I., AKI, E., HAJÓS, G., “Ring Expansion of N-Aminobenzothiazolium Salts to Benzothiazines and Benzothiadiazines” Acta Chim. Slov., 56, 622–628, (2009).

[50] ERTAN, T., YILDIZ, I., TEKINER-GULBAS, B., BOLELLI, K., TEMIZ-ARPACI, O., OZKAN, S., KAYNAK, F., YALCIN, I., AKI, E., “Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents”, European Journal of Medicinal Chemistry, 44, 501–510, (2009).

[51] ZEYBEK, B., DURMUS, Z., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., KILIC, E., “Electrochemical Behaviors and Determinations of Some 2,5-Disubstituted Benzoxazole Compoumds at the HAnging Mercury Drop Electrode”, Current Pharm. Analysis, 5, 21-27, (2009).

[52] AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., “DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships”, Medicinal Chemistry Research, 19 (Suppl. 1), S6, 2010.

[53] YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Medicinal Chemistry Research, 19 (Suppl. 1), S41, 2010.

[54] TASKIN,T., YILMAZ, S., YILDIZ, I. YALCIN, I., AKI, E., “Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking” SAR and QSAR in Environmental Research ,. 23( 3–4), 345–355 (2012).

[55] BOLELLI, K., YALCIN, I., ERTAN-BOLELLI, T., ÖZGEN, S., KAYNAK-ONURDAG, F., YILDIZ, I., AKI, E.” Synthesis of novel 2-[4-(4-substituttedbenzamido/phenylacetamido)phenyl] benzothiazoles as antimicrobial agents” Med. Chem. Res. 21:3818–3825 (2012).

[56] YILMAZ, S., YALCIN, I., KAYNAK-ONURDAG, F., OZGEN, S., YILDIZ, I., AKI, E., Synthesis And In Vitro Antimicrobial Activity Of Novel 2-(4-(Substituted Carboxamido)Benzyl/Phenyl)Benzothiazoles, Croatica Chemica Acta, 86(2), 223-231, 2013.

[57] YILMAZ, S., YALCIN, I., KAYNAK-ONURDAG, F., OZGEN, S., YILDIZ, I., AKI, E., Synthesis and In vitro Antimicrobial Activity of Novel 2-(4-(Substituted-

6

carboxamido)benzyl / phenyl)benzothiazoles, Croatica Chemical Acta, 86(2), 223-231, 2013.

[58] BHAGYASREE, J.B., VARGHESE, H.T., PANICKER, C.Y., SAMUEL, J., VAN ALSENOY, C., BOLELLI, K., YILDIZ, I., AKI, E, Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy 102, 99-113, 2013.

[59] BHAGYASREE, J.B., VARGHESE, H.T.,YOHANNAN PANICKER, C., SAMUEL, J., VAN ALSENOY, C., YILMAZ, S., YILDIZ, I., AKI, E. Quantum mechanical and spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations of 2-(p-nitrobenzyl) benzoxazole , Journal of Molecular Structure 1046 , 92-100, 2013.

[60] KAPLAN-OZEN, C., TEKINER-GULBAS, B., FOTO, E., YILDIZ, I., DIRIL, N., AKI, E., YALCIN, I., "Benzothiazole derivatives as human DNA topoizomerase IIα inhibitors", Med. Chem. Res., 22(12), 5798-5808, (2013).

[61] AKI-YALCIN, E., ERTAN-BOLELLI, T., TASKIN-TOK, T., OZTURK, O., ATAEI, S., OZEN, C., YILDIZ, I., YALCIN, I., "Evaluation of Inhibitory Effects of Benzothiazole and 3-Amino-benzothiazolium Derivatives on DNA Topoisomerase II by Molecular Modeling Studies", SAR and QSAR in Environmental Research, 25(8), 637-649, (2014). doi:10.1080/1062936X.2014.923039.

[62] ERTAN-BOLELLI, T., MUSDAL, Y., BOLELLI, K., YILMAZ, S., AKSOY, Y., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Synthesis, Biological Evaluation of 2-Substituted-5-(4-nitrophenylsulfonamido) benzoxazoles as Human GST P1-1 Inhibitors and Description of the Binding Site Features”, ChemMedChem,9(5), 984-992, (2014). doi:10.1002/cmdc.201400010.

[63] YILMAZ, S., ALTINKANAT-GELMEZ, G., BOLELLI, K., GUNESER-MERDAN, D., OVER-HASDEMIR, M. U., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Pharmacophore Generation of 2-Substituted Benzothiazoles as AdeABC Efflux Pump Inhibitors in A. baumannii”, SAR and QSAR in Environmental Research, 25(7), 551-563, (2014). doi:10.1080/1062936X.2014.919357 .

[64] ZILIFDAR, F., ALPER-HAYTA, S., YILMAZ, S., KAPLAN-OZEN, C., FOTO, E., AYDOGAN, Z., YILDIZ, I., AKI, E., YALCIN, I., DIRIL, N., "Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives", Med. Chem. Res., 23(1), 480-486, (2014).

[65] SERAP YILMAZ, GULSEN ALTINKANAT-GELMEZ, KAYHAN BOLELLI, DENIZ GUNESER-MERDAN, M. UFUK OVER-HASDEMIR, ESIN AKI-YALCIN, ISMAIL YALCIN, "Binding Site Feature Description of 2-Substituted Benzothiazoles as AcrAB-TolC Efflux Pump Inhibitors in E. coli", SAR and QSAR in Environmental Research, 1-25 (2015). DOI:10.1080/1062936X.2015.1106581.

7

[66] ANDRY NUR HIDAYAT, ESIN AKI-YALCIN, MERAL BEKSAC, ERMING TIAN, SAAD Z. USMANI, TUGBA ERTAN-BOLELLI, ISMAIL YALCIN, "Insight into Human Protease Activated Receptor-1 as Anticancer Target by Molecular Modeling", SAR and QSAR in Environmental Research, 1-23 (2015). DOI:10.1080/1062936X.2015.1095799.

[67] TUGBA ERTAN-BOLELLİ, KAYHAN BOLELLİ, SUZAN OKTEN, FATMA KAYNAK-ONURDAG, ESİN AKİ-YALCİN, ISMAİL YALCİN, "Synthesis, Antimicrobial Activities of New Sulfonamidobenzoxazoles and Molecular Docking Studies on Escherichia coli TEM-1 β-Lactamase", Croatica Chemica Acta, 90(1), 67-74 (2017). DOI: 10.5562/cca3111.

[68] TUGBA ERTAN-BOLELLİ*, KAYHAN BOLELLİ, YAMAN MUSDAL, ILKAY YİLDİZ, ESİN AKİ-YALCİN, BENGT MANNERVİK, ISMAİL YALCİN, "Design and synthesis of 2-substituted-5-(4-trifluoromethylphenylsulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors", Artificial Cells, Nanomedicine, and Biotechnology, 45, 1-8 (2017). Doi: 10.1080/21691401.2017.1324464.

A.1. 2. Other International Journals [69] TURKER, L., SENER, E., YALÇIN, I., AKBULUT, U., KAYALIDERE, I., QSAR

of Some Antifungal Active Benzoxazoles Using The Quantum Chemical Parameters, Scientica Pharmaceutica, 58, 107-113 (1990).

[70] YALCIN, I., SENER, E. and OREN, I., QSAR of some antibacterial active isosteric heterocyclic compounds against an enterobacter. In Wermuth, C. G. (Ed.) Trends in QSAR and Molecular Modelling 92. Escom, Leiden, pp. 570-572 (1993).

[71] GULLU, M., YALCIN, I., SENER, E., TURKER, L., CELEBI, N., AKBULUT, U., Relationships Between Cathodic Peak Potentials and Theoretically Calculated LUMO Energies of Some 2-Phenybenzoxazole Derivatives, Bulletin Soc. Chim. Belg, 103(3), 87-90 (1994).

[72] YALCIN, I., SENER, E., OREN, I., TEMIZ, O., Determination of the activity contributions of some novel isosteric heterocyclics against an enteric gram-negative rod using the Free-Wilson analysis. In Sans, F., Giraldo, J. and Manaut, F. (Eds.) QSAR and Molecular Modelling:Concepts, Computational Tools and Biological Applications. Prous, Barcelona, pp. 147-151 (1995).

[73] TURKER, L., GULLU, M., YALCIN, I., SENER, E., CELEBI, N., Relationships Between Theoretically Calculated LUMO Energies and Cathodic Peak Potentials of Some 2-Benzylbenzoxazole Derivatives, Bulletin Soc Chim. Belg, 105 (6), 303-306 (1996).

[74] TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, I., "3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis Method", QSAR and Molecular Modelling in Rational Design of Bioactive

8

Molecules, Istanbul-Turkey, September 5-10, 2004, AKI-ŞENER, E., YALÇIN, İ. (Eds.), Başkent Publishing, Ankara, (2006).

A. 2. NATIONAL PAPERS [75] NOYANALPAN, N., SENER, E., “Synthesis, Structure Elucidation and

Antihistaminic Activities of 2-(p-Substitutedbenzyl)benzoxazole Derivatives” FABAD J. of Pharmaceutical Sciences, 10(4), 275-286 (1985) (Turkish).

[76] YALÇIN, I., ŞENER, E., ÖZDEN, T., “Synthesis and Structure Elucidation of 2-(p-Substitutedphenyl)oxazolo (4,5-b)pyridine Derivatives” J. of Ankara University Faculty of Pharmacy, 15(1), 67-78 (1985) (Turkish).

[77] NOYANALPAN, N., ŞENER,.E., “Synthesis, Structure Elucidation and Antihistaminic Activities of 5-Chloro-2-(p-Substitutedbenzyl)benzoxazole Derivatives”, FABAD J. of Pharmaceutical Sciences, 11(1), 22-30 (1986) (Turkish).

[78] NOYANALPAN, N., ŞENER, E., “Synthesis, Structure Elucidation and Antihistaminic Activities of 5-Nitro-2-(p-Substitutedbenzyl)benzoxazole Derivatives”, FABAD J. of Pharmaceutical Sciences, 11(2), 111-119 (1986) (Turkish).

[79] ŞENER, E., ÖZDEN, S., YALÇIN, İ., ÖZDEN, T. , AKIN, A., YILDIZ, S., “Synthesis, Structure Elucidation and Microbiological Activities of 2-(p-Substitutedphenyl)benzoxazole Derivatives” J. of Ankara University Faculty of Pharmacy, 11(3), 190-202 (1986) (Turkish).

[80] YALÇIN, İ., ŞENER, E., ÖZDEN, T., ÖZDEN, S., AKIN, A., YILDIZ, S., “Synthesis, Structure Elucidation and Microbiological Activities of 5-Chloro-2-(p-Substitutedphenyl)benzoxazole Derivatives” FABAD J. of Pharmaceutical Sciences, 11(4), 257-269 (1986) (Turkish).

[81] ÖZDEN, S., ÖZDEN, T., ŞENER, E., YALÇIN, İ., AKIN, A., YILDIZ, S., “Synthesis, Structure Elucidation and Microbiological Activities of 5-Nitro-2-(p-Substitutedphenyl)benzoxazole Derivatives” FABAD J. of Pharmaceutical Sciences, 12(1), 39-47 (1986).

[82] YALÇIN, İ., ŞENER, E., ÖZDEN, S., AKIN, A., YILDIZ, S., The Quantitative Structure-Activity Relationships and Antibacterial Activty of 2-(p-Substitutedphenyl) oxazole(4,5-b)pyridine derivatives Against Streptococcus faecalis ve Staphylococcus aereus, FABAD J. of Pharmaceutical Sciences, 12(3), 213-222 (1987).

[83] ŞENER, E., YALÇIN, İ., E., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole derivatives Against Gram (-) Bacteria Using The Combinations of Some Hydrophobic, Electronic and Steric Paramaters, J. of Gazi University Faculty of Pharmacy, 3(2), 133-142 (1986).

[84] YALÇIN, İ., ŞENER, E.,., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole Derivatives Against Candida albicans Using The Combinations of Some

9

Hydrophobic, Electronic and Steric Paramaters, J. of Ankara University Faculty of Pharmacy,16(1), 24-30 (1986).

[85] YALÇIN, İ., ŞENER, E., E., ÖZDEN, S., ÖZDEN, T., The Quantitative Structure-Activity relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole Derivatives Against Gram (+) Bacteria Using The Combinations of Some Hydrophobic, Electronic and Steric Paramaters, FABAD J. of Pharmaceutical Sciences, 12(1), 48-55 (1987).

[86] ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T. , AKIN, A., YILDIZ, S., The Antifungal Activity of 2-(p-Substitutedphenyl)oxazolo(4,5-b)pyridine Derivatives Against Candida albicans and The Quantitative Structure-Activity Relationships, FABAD J. of Pharmaceutical Sciences, 12(4), 281-288 (1987).

[87] ŞENER, E., YALÇIN, İ., E., ÖZDEN, S., ÖZDEN, T. , AKIN, A., YILDIZ, S., Synthesis and Antimicrobial Activities of 5-Amino-2-(p-substitutedphenyl)-benzoxazole Derivativies, Doga Turkish Journal of Medicine and Pharmacy, 11(3), 391-396 (1987).

[88] ŞENER, E., YALÇIN, İ., AKIN, A., NOYANALPAN, N., Antifungal Activity of 2-Benzylbenzoxazole Derivativies and QSAR’s by Free-Wilson Analysis, J. of Gazi University Faculty of Pharmacy, 4(1), 1-9 (1987).

[89] YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., AKIN, A., YILDIZ, S., The Antibacterial Activity of 2-Phenyloxazolo(4,5-b)pyridine Derivatives Against Gram(-) Bacteria and The Quantitative Structure-Activity Relationships, FABAD J. of Pharmaceutical Sciences, 13(3), 441-449 (1988).

[90] ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., AKIN, A., UÇARTÜRK, N., Synthesis, Antibacterial Activity and QSARs of Some 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles Using The Free-Wilson Analysis, J. of Ankara University Faculty of Pharmacy, 24(1), 10-20, (1995).

B- REVIEWS [91] BÜYÜKBINGÖL, E., ŞENER, E., “Quantitative Structure-Activity Relationships in

Medicinal Chemistry” Pharmacia-J of Turkish Pharmacy Association, 24: 52(2), 126-133, (1984) (Turkish).

[92] YALÇIN, İ., ŞENER, E., “The Quantitative Structure-Activity Relationships of Selective Antiinflammatuary Active Nonacidic Poliaryl Heterocyclic Compounds”, FABAD J. of Pharmaceutical Sciences, 10(3), 183-194 (1985) (Turkish).

[93] ŞENER, E., YALÇIN, İ., “The Role of Histamine in Inflammation, The Effects of Antihistaminics in Inflammation and Antiinflammatory Compounds Against Histamine , J of Ankara Pharmacy Chamber, 8(2),99-110 (1986) (Turkish).

[94] YALÇIN, İ., ŞENER, E., Research and Development Studies on Antiinflammatory, Analgesic and Antipiretic Kinazolone Derivatives” J of Ankara Pharmacy Chamber, 8(4), 269-276 (1986) (Turkish).

10

[95] Ö TEMİZ, Ö., ŞENER, E., Microbiological Activity Benzoxazole, Benzimidazole, Benzothiazole ve Oxazolo(4,5-b)pyridine Derivatives, J. of Ankara University Faculty of Pharmacy, 21(1-2), 36-52, (1992).

[96] Ö TEMİZ, Ö., ŞENER, E., “New Benzodiazepine Derivatives and Their Biologic Activities, J. of Ankara University Faculty of Pharmacy, 23(1-2), (1994) (Turkish).

[97] YALÇIN, İ., ŞENER, E., “The Importance, Design and Development of Original Drug Studies in Turkey” Reports of Turkish Drug and Chemistry, 99-100-101, s. 4-5 (1996) (Turkish).

[98] ALPER, S., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ.,”Some New bi-and ter-benzimidazole Derivatives as Topoisomerase I Inhibitors”, Il Farmaco, 58, 497-507, (2003).

C - BOOKS [1] ESİN AKI-ŞENER, İSMAİL YALÇIN, “Drug Design Methods in

Pharmaceutical/Medicinal Chemistry-I, Quantitative Structure-Activity Relationship Analysis (QSAR)”, Ankara University Faculty of Pharmacy Publications, No:86, ISBN 975-482-585-8, Ankara University Press, 2003, 323 pages (Turkish).

[2] “Pharmaceutical Chemistry Practices-I” Ankara University Press, 2004, ISBN 975-482-649-8, 18 Authors, (Turkish).

[3] “Pharmaceutical Chemistry Practices-I” Ankara University Press,2004, ISBN 975-482-668-4, 18 Authors, (Turkish).

[4] "QSAR & Molecular Modelling in Rational Design of Bioactive Molecules, Proceeding Book of the 15th European Symposium on Structure-Activity Relationships (QSAR) and Molecular Modelling", Esin AKI (SENER) and Ismail YALCIN (Eds.), printed by Başkent Publishing, ISBN 975-00782-0-9, 2006.

D- PRESENTATIONS

D.1. ORAL PRESENTATIONS & INVITED LECTURES D.1.1. National Presentations

1. YALCIN, I., SENER, E., OZDEN, S., OZDEN, T., “Quantitative Structure

Activity Relationships of 5-Nitro-2-p-substitutedphenyl) benzoxazole derivatives against Candida albicans”, Chemistry and Chemistry Engineering Symposium, Ankara, Turkey, Abs. Book. Pg 68, 17-20 September 1986.

2. YALCIN, I., SENER, E., OZDEN, S., OZDEN, T., “Quantitative Structure Activity Relationships of antibacterial active 2-(p-substitutedphenyl) benzoxazole derivatives against Gram-negative Bacteria” Chemistry and Chemistry Engineering Symposium, Ankara, Turkey, Abs. Book. Pg 69, 17-20 September 1986.

11

3. SENER, E., YALCIN, I., SUNGUR, E., Computer Aided Drug Design; Hansch Analysis” Computer Aplications in Medical Sciences II”, Izmir, Turkey, 26-29 September 1988.

4. YALCIN, I., SENER, E., Computer Aided Drug Design; Free-Wilson Analysis” Computer Aplications in Medical Sciences II”, Izmir, Turkey, 26-29 September 1988.

5. SENER, E., YALÇIN, I., SUNGUR, E., Kantitatif Yapı-Etki İlişkileri Analizi Yardımı ile Bir İlaç Etken Madde Tasarım Çalışmaları, Uluslararası Katılımlı I. Eczacılık Bilimleri Sempozyumu, Özet Kitabı S11, 21-23 Haziran 1989.

6. AKI, E., “Rasyonel İlaç Tasarım Yöntemleri”, 13. Biyomedikal Mühendisliği Ulusal Toplantısı, Ankara, Türkiye, 29-31 Mayıs, 2008.

7. AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., TASKIN, T., YILMAZ, S., “Kemoterapötik Etkili Bileşiklerin Bilgisayar Destekli İlaç Tasarım Çalışmaları”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, IL-009, Sayfa 43, Erzurum, Türkiye, 18-22 Mayıs 2011.

8. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

9. AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., TASKIN, T., YILMAZ, S., “Kemoterapötik Etkili Bileşiklerin Bilgisayar Destekli İlaç Tasarım Çalışmaları”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, IL-009, Sayfa 43, Erzurum, Türkiye, 18-22 Mayıs 2011.

10. TASKIN-TOK, T., AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., YILMAZ, S., “Docking Studies of Topoisomerase II Inhibitors”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, MS-013, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

11. ESIN AKI, İSMAIL YALÇIN, İLKAY YILDIZ, BETÜL TEKINER-GÜLBAŞ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, ÖZÜM ÖZTÜRK, Chemometrics in Drug Design, NTCA-2011, 08-11 October 2011, Antalya IL-05: p7.

D.1.2 – International Presentations

12. SENER, E., TEMIZ, O., OREN, I., YALCIN, I., ALTANLAR, N., Synthesis and QSAR Analysis of Some Novel 2,5-Disubstituted Benzoxazoles Against B. subtilis., Second International Meeting on Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, Abstracts O9, 06-09 September 1998.

13. SENER, E., OREN, I., TEMIZ-ARPACI, O., BINGOL, K. K., YALCIN, I., QSARs of Some Novel Antibacretial Active Isosteric Heterocyclics Against

12

Bacillus Subtilis., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract O-23, 22-24 September 1999.

14. SENER, E., OREN, I., ARPACI-TEMIZ, YALCIN, I., “3-D QSAR of Some Antibacterial Active Heterocyclic Compounds Using the CoMSIA Method” 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, Abstracts 136, 27-29 September 2000.

15. YALCIN, I.; SENER, E., ARPACI-TEMIZ, O., Tekiner, B. “3-D QSAR of Some Antibacterial Active Heterocyclics Using the CoMSIA Method” 3rd International Symposium on Pharmaceutical Chemistry, Istanbul, Turkey, Abstracts 90, 17-19 September 2001.

16. AKI-SENER, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., ALPER, S., ZAFER, B., “Studies on Pharmacophore Group Identification of Topoisomerase II Inhibitory Active Fused Heterocyclics Using CATALYST HipHop”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 19, 13-14 May, 2005.

17. LAGE, H., AKI-ŞENER, E., YALCIN, I., “High Antineoplastic Efficiency of Heterocyclic DNA Topoisomerase II Inhibitors in Classical and Atypical Multidrug-Resistant Cancer Cells”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 25, 13-14 May, 2005

18. KERBOEUF, D., KOCH, C., GUEGNARD, F., TEKİNER-GULBAS, B., AKI-SENER, E., YALCIN, I., “Some Fused Heterocyclic Compounds as Anthelmintic against Haemonchus conttortus, Nematode parasite of Ruminants”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 37, 13-14 May, 2005

19. AKI-SENER, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., ALPER, S., ZAFER, B., “Studies on Pharmacophore Group Identification of Topoisomerase II Inhibitory Active Fused Heterocyclics Using CATALYST HipHop”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 19, 13-14 May, 2005.

20. LAGE, H., AKI-SENER, E., YALCIN, I., “High Antineoplastic Efficiency of Heterocyclic DNA Topoisomerase II Inhibitors in Classical and Atypical Multidrug-Resistant Cancer Cells”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 25, 13-14 May, 2005

21. KERBOEUF, D., KOCH, C., GUEGNARD, F., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., “Some Fused Heterocyclic Compounds as Anthelmintic against Haemonchus conttortus, Nematode parasite of Ruminants”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 37, 13-14 May, 2005.

22. AKI-SENER, E., YALCIN, I., YILDIZ, I., TEMIZ ARPACI, O., ZAFER, B., TEKINER-GULBAS; B., “3D-QSAR Studies of Topoisomerase II Inhibitors Using Catalyst ” Watoc`05, Modelling Structure and Reactivity 7th Congress of the World Association of Theoretically Oriented Chemists, Cape Town, South Africa, Abstract C12-5, 16-21 January 2005.

23. YILDIZ, I., YALCIN, İ., AKI-SENER, E., TEMIZ ARPACI, O., TEKINER-GULBAS; B., “3D-QSAR Studies on Some Topoisomerase II Inhibitors” 3rd International Symposium Computational Methods In Toxicology &Pharmacology

13

Integrating Internet Resources (CMTPI-2005), Shanghai, P.R: China, Abstract ORB-06, October 29th- November 1st, 2005.

24. YALCIN, I., AKI-SENER, E., YILDIZ, I. “Studies on pharmacophore identification of topoisomerase II inhibitors using catalyst HipHop” 18 Conferincia de quimica Santiago de Cuba, Cuba, TM-PO2, Abstract page 6-9 December 2005.

25. TEMIZ ARPACI, O., OKSUZOGLU, E., TEKINER-GULBAS; B., ZAFER, B., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.

26. YALCIN, I., AKI-SENER, E., YILDIZ, I., TEMIZ ARPACI, O., TEKINER-GULBAS, B., “Research results incorporated on COST B16 Action from the year 2003 to 2006”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-04, 22-25 April 2006.

27. AKI-SENER, E., YALCIN, I., ALPER-HAYTA, S., TEKINER-GULBAS, B., TEMIZ ARPACI, O., YILDIZ, I., ALTANLAR, N., “Synthesis, antimicrobial activity and QSARs of New Benzoxazine-3-ones”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-10, 22-25 April 2006.

28. PINAR, A., YURDAKUL, P., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, I., ILERI, O., “Eukaryotic Topoisomerase II activity of some novel fused heterocyclic compounds”, 31st FEBS Congress, İstanbul, Turkey, 24-29 June 2006.

29. TEMIZ ARPACI, O., OKSUZOGLU, E., TEKINER-GULBAS, B., ZAFER, B., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.

30. YILDIZ, I., ALPER, S., ERTAN, T., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Molecular Modeling Studies on Some Eucaryotic Topoisomerase II Enzyme Inhibitor Fused Heterocyclic Compounds", 6th AFMC International Medicinal Chemistry Symposium, Istanbul-TURKEY, July 08-11, 2007.

31. YALCIN, I., AKI-SENER, E., YILDIZ, I., TEMIZ-ARPACI, O., ZAFER, B., TEKINER-GULBAS, B., ALPER, S., “Pharmacophore Analysis of topoisomerase II inhibitory active benzazoles”, CMPTI-2007, MT-17, Moscow, Russia, Sept. 01-05, 2007.

32. AKI, E., “General Aspects of Drug Design”, International Seminar on Pharmaceutical Education and Research”, Kashipur, India, p. 21, 23 Feb 2010.

33. YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Medicinal Chemistry Research, 19 (Suppl. 1), S41, 2010.

34. AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., TASKIN, T., YILMAZ, S., “Kemoterapötik Etkili Bileşiklerin Bilgisayar Destekli

14

İlaç Tasarım Çalışmaları”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, IL-009, Sayfa 43, Erzurum, Türkiye, 18-22 Mayıs 2011.

35. ESIN AKI, İSMAIL YALÇIN, İLKAY YILDIZ, BETÜL TEKINER-GÜLBAŞ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, ÖZÜM ÖZTÜRK, Chemometrics in Drug Design, NTCA-2011, 08-11 October 2011, Antalya IL-05: p7.

36. ESIN AKI, TUGBA TASKIN, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ, ISMAIL YALCIN, YAMAN MUSDAL, YASEMIN AKSOY. Molecular Modelling Studies on the Design of Chemotherapeutically Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26.

37. ESIN AKI, TUGBA TASKIN, YAMAN MUSDAL, YASEMIN AKSOY, SERAP YILMAZ, TUĞBA ERTAN-BOLELLI, KAYHAN BOLELLI, ILKAY YILDIZ, ISMAIL YALCIN. Docking Studies of GST Inhibitory Active 2-Substituted Benzazoles, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources. 3-7 September 2011, Maribor, Slovenia, Major Talk p.43.

38. TASKIN-TOK, T., AKI, E., YALCIN, I., YILDIZ, I., ERTAN-BOLELLI, T., BOLELLI, K., YILMAZ, S., “Docking Studies of Topoisomerase II Inhibitors”, 25. Uluslararası Katılımlı Ulusal Kimya Kongresi, MS-013, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

39. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

40. ISMAIL YALCIN, KAYHAN BOLELLI, SERAP YILMAZ, ILKAY YILDIZ, ESIN AKI, Common Feature Pharmacophore Generation of Heterocyclic Compounds Against Efflux pump Over-expressor Bacteria, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources. 3-7 September 2011, Maribor, Slovenia, p.67.

41. ISMAIL YALCIN, ESIN AKI, ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ. QSAR and Molecular Modeling Studies on Chemotherapeutic Active Benzazoles. AIMECS11 29 November-2 December 2011 Tokyo, IL-B1:p8.

42. ESIN AKI, İSMAIL YALÇIN, ILKAY YILDIZ, TUĞBA TAŞKIN, TUĞBA ERTAN-BOLELLI, SERAP YILMAZ, KAYHAN BOLELLI, Structure Based Drug Design Methods, 2nd International Conference on Computation for Science and Technology, 09-11 July 2012, Nigde, Invited Lec-7:p52.

43. ISMAIL YALCIN, ESIN AKI, ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ. Computational Methods in Rational Drug Design, 2nd International Conference on Computation for Science and Technology, 09-11 July 2012, Nigde, Plenary Lec-5:p43.

44. ESIN AKI-YALCIN, ISMAIL YALCIN, ILKAY YILDIZ, TUĞBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, ÖZÜM ÖZTÜRK.

15

Chemometrics in Drug Design, 2st International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, IL-05: p7, 25-28 October 2013.

45. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, TUGBA TASKIN-TOK, ILKAY YILDIZ AND ISMAIL YALCIN. Rational Design of DNA-Topoisomerase Inhibitory Active Benzazoles as Antitumoral Agents, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, O-37: p54, 15-18 October 2013.

46. ISMAIL YALCIN, KAYHAN BOLELLI, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, ESIN AKI-YALCIN. CADD Studies on Chemotherapeutical Active Fused Heterocyclic Compounds, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, S18-01: p55, 15-18 October 2013.

47. ESIN AKI, TUGBA TASKIN, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ, ISMAIL YALCIN, YAMAN MUSDAL, YASEMIN AKSOY. Molecular Modelling Studies on the Design of Chemotherapeutically Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26.

48. ISMAIL YALCIN, SERAP YILMAZ, KAYHAN BOLELLI, TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, ESIN AKI-YALCIN. Common Feature Pharmacophore Generation of Heterocyclic Compounds as Bacterial RND Efflux Pump Inhibitors, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-2: p27.

49. Esin AKI-YALÇIN, Ilaç Tasarımında Moleküler Modelleme Yöntemleri, İalç Araştırmalarında Uygulamalı Moleküler modelleme ve Simulasyon Teknikleri Kursu, 20-22 Şubat 2013, Hacettepe Üniversitesi.

50. ESIN AKI-YALCIN, TUGBA TASKIN-TOK, TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, ISMAIL YALCIN. Molecular Docking Analysis of Benzothiazole derivatives as human DNA topoisomerase II inhibitors, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, IS-09: p39, 8-12 October 2013.

51. ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, YAMAN MUSDAL, KAYHAN BOLELLI, SERAP YILMAZ, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Computer Aided Molecular Modeling of the Binding Site and GSH Conjugation Features of the New Human GST P1-1 Inhibitors, The 3rd International Conference on Computation for Science and

16

Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, PL-03: p6, 23-25 September 2014.

52. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, TUGBA TASKIN-TOK, ANDRY NUR HIDAYAT, ILKAY YILDIZ, ISMAIL YALCIN. Anticancer Drug Design Studies using Molecular Modeling Techniques, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, IS-02: p10, 23-25 September 2014.

53. TUGBA ERTAN-BOLELLI, ISMAIL YALCIN, YAMAN MUSDAL, SERAP YILMAZ, KAYHAN BOLELLI, OZUM OZTURK, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Molecular Docking Studies on Human Glutathione S-transferase Enzyme (hGSTP1-1), The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P13: p28, 23-25 September 2014.

54. SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, ESIN AKI-YALCIN, ISMAIL YALCIN. Computational Drug Design Studies for Multidrug Resistance AcrAB-TolC Efflux Pump Inhibitors on Escherichia coli, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P106: p62, 23-25 September 2014.

55. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, TUGBA TASKIN-TOK, CIGDEM OZEN, KAYHAN BOLELLI, SERAP YILMAZ, OZUM OZTURK, ILKAY YILDIZ, ISMAIL YALCIN. Identification of Mechanism of Action of DNA-Topoisomerase II Inhibitors by Molecular Modeling Studies, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, OC12: p52, 31 August - 4 September 2014.

56. ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, YAMAN MUSDAL, KAYHAN BOLELLI, SERAP YILMAZ, YASEMIN AKSOY, BENGT MANNERVIK, ILKAY YILDIZ, ESIN AKI-YALCIN. Description of the Binding Site Features of Some Fused Heterocycles as New Human GST P1-1 Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-5: p9, 17-19 April 2014.

57. ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, TUGBA TASKIN-TOK, SERAP YILMAZ, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ AND ISMAIL YALCIN. Molecular Modeling Studies on DNA-Topoisomerase II Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IL-8: p18, 17-19 April 2014.

17

58. ILKAY YILDIZ, SANAZ ATAEI, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, EGEMEN FOTO, ESIN AKI-YALCIN, ISMAIL YALCIN. Molecular Modeling Studies On Some Topoisomerase I Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, OP-1: p38-39, 17-19 April 2014.

59. E. Aki-Yalcin, O. Ozturk, T. Ertan-Bolelli, K. Bolelli, S. Yilmaz, A. H. Nur, O. Bingol-Ozakpinar, and F. Ozdemir. Mechanism of Action of Some New Anticancer Active Neurokinin-1 (NK1) Receptor Antagonists, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-4: p256, 18-21 October 2015.

60. Ismail Yalcin, Serap Yilmaz, Gulsen Altinkanat-Gelmez, Kayhan Bolelli, Deniz Guneser-Merdan, M. Ufuk Over-Hasdemir, Esin Aki-Yalcin. Binding Site Description Of Benzothiazoles As the RND Efflux Pump Acrb Inhibitors, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-14: p30, 1-3 October 2015.

61. Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan-Bolelli, Andry Nur Hidayat, Ozlem Bingol-Ozakpinar, Filiz Ozdemir, Ismail Yalcin. Mechanism of Action of Neurokinin-1 Receptors as an Anticancer Target, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-22: p39-40, 1-3 October 2015.

62. Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Tugba Ertan-Bolelli, Esin Aki-Yalcin. Description of the Binding Site Features of AcrAB-TolC Efflux Pump Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-11: p44, 21-25 June 2015.

63. Esin Akı-Yalcin, Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, A.H. Nur, S. Sahin, Ismail Yalcin, Ozlem Bingol-Ozakpinar, Filiz Ozdemir. Molecular Modeling Studies on Neurokinin 1 (NK1) Receptors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-12: p47, 21-25 June 2015.

64. Andry Nur Hidayat, Esin Akı-Yalcin, Ismail Yalcin, Meral Beksac, Erming Tian, Saad Z. Usmani. Docking Study of Human Protease Activated Receptor 1 (PAR1) Antagonists, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, OC-28: p53, 21-25 June 2015.

65. Esin Aki-Yalcin, Ismail Yalcin, Tugba Ertan-Bolelli, Serap Yilmaz, Kayhan Bolelli, Özüm Öztürk, Tugba Taskin-Tok, Emine Öksüzoglu, Cigdem Özen-

18

Kaplan. Computer aided drug design studies for new anticancer drugs, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, Closing Lecture: p38, 18-19 May 2015.

66. Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ismail Yalcin, Esin Aki-Yalcin. Molecular Docking Analysis of Benzothiazole/Benzothiazolium Derivatives as Human DNA Topoisomerase II Inhibitors, BIOVIA Turkish Regional User Meeting with A-Ztech Ltd., ByOtell Hotel, Istanbul, Turkey, 10 April 2015.

D.2.POSTER PRESENTATIONS D.2.1. National Presentations 67. SENER, E., TURGUT, H., “Synthesis, Structure Elucidation and Microbiological

Activity of Some 5-Substituted-2-(3-pyridyl)benzoxazole Derivatives”, I. Pharmaceutical Sciences Symposium”, Ankara, Turkey, Abs Book pg 31, 21-23 September 1990.

68. ZEYBEK, B., DURMUS, Z., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., KILIC, E. “Electrochemical Behaviour of Some Benzoxazole Derivatives” XIX. National Chemistry Symposium, AKP 72, , Kusadası, Turkey, 30 September-4 October 2005.

69. BOLELLİ, K., ERTAN-BOLELLI, T., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-[4-(4-Sübstitüebenzamido)fenil]benzotiyazol Türevlerinin 1H-NMR Spektroskopi Çalışmaları”, P-210, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

70. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

71. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

72. İLKAY YILDIZ, SERAP YILMAZ, SANAZ ATAEI, ESIN AKI, İSMAIL YALÇIN.Pharmacophore Analysis of Some Aromathecins as Topoisomerase I Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-36: p63.

73. KAYHAN BOLELLI, SERAP YILMAZ, İSMAIL YALÇIN, İLKAY YILDIZ, ESIN AKI, QSAR Analysis of Some 2-Substituted Benzothiazoles as Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus, NTCA-2011, 08-11 October 2011, Antalya PP-37: p64.

19

74. SERAP YILMAZ, İLKAY YILDIZ, ESIN AKI, İSMAIL YALÇIN.3D Pharmacophore Modelling of Some Fused Heterocyclic compounds as Topoisomerase II Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-38: p65.

75. TUGBA ERTAN-BOLELLI, İLKAY YILDIZ, SELDA ÖZGEN, ESIN AKI, İSMAIL YALÇIN. QSAR Analysis of Some Novel 2-(p-Substitutedphenyl/benzyl)-5-(p-substitutedbenzensulfonamido) benzoxazoles against Mycobacterium tuberculosis isolate, NTCA-2011, 08-11 October 2011, Antalya PP-39: p66.

76. BOLELLİ, K., ERTAN-BOLELLI, T., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-[4-(4-Sübstitüebenzamido)fenil]benzotiyazol Türevlerinin 1H-NMR Spektroskopi Çalışmaları”, P-210, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

77. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

D.2.2. International Presentations

78. YALCIN, I., SENER, E., OREN, I., AKIN, A., QSARs of Some Antifungal Active

Benzoxazoles and Oxazolo(4,5-b)pyridines by Free-Wilson Analysis, 50th International Congress of F.I.P., Istanbul, Abstracts CS181, 03-07 September 1990.

79. YALCIN, I., SENER, E., OREN, I., QSARs of Some Antibacterial Active Isosteric Heterosiclic Compounds Against an Enterobacter, 9th European Symposium On Structure-Activity Relationships: QSAR and Molecular Modelling, Strasbourg, France, Abtracts p129, 07-11 September 1992.

80. SENER, E., YALCIN, I., TEMIZ, O., OREN, I., AKIN, A., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles Against An Enteric Gram-Negative Rod, XIIth International Symposium On Medicinal Chemistry, Basel, Switzerland, Abstracts P-005. B, 13-17 September 1992.

81. SENER, E., TEMIZ, O., YALCIN, I., OREN, I., AKIN, A., UCARTURK, N., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substituted benzyl) benzoxazoles Against Staphylococcus aureus, 3rd International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P20, 15-18 September 1993.

82. YALCIN, I., SENER, E., OREN, I., TEMIZ, O., Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics against an Enteric Gram-negative Rod using the Free-Wilson Analysis, 10th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling, Barcelona, Spain, Abstracts P-169A, 4-9 September 1994.

83. OREN, I., YALÇIN, I., TEMIZ, O., SENER, E.,Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics Against a Fungi Candida

20

albicans Using The Free-Wilson Analysis, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P106, 27-30 September 1995.

84. SENER, E., YALCIN, I., TEMIZ, O., OREN, I., BINGOL, K. K., AKIN, A., UCARTURK., The Synthesis and Antimicrobiological Activity of Some 2,5-Disubstituted Benzoxazole and Imidazole Derivatives, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P109, 27-30 September 1995.

85. WOJCIECHOWSKA, J. K., MROZEK, A., YALCIN, I., SENER, E., Crystal and Molecular Structure of 5-Chloro-2-(p-ter-buthylphenyl)benzoxazole, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P113, 27-30 September 1995.

86. WOJCIECHOWSKA, J. K., MROZEK, A., YALCIN, I., SENER, E., Electronic Conditions For Antimicrobial Activity of 2,5-Disubstituted Benzoxazole Derivatives, 5th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 4, pg 44, 21-24 August 1995.

87. YALCIN, I., SENER, E., OREN, I., Activity Contributions of Some Novel Isosteric Heterocyclics Against Nosocomial Infection Caused Gram-Negative Rod Using The Free-Wilson Analysis, 1995 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 6-11 August 1995.

88. SENER, E., OREN, I., TEMIZ, O. and YALCIN, I. “Synthesis and Antimycotic Activity of Some 2, 5, 6-Trisubstituted Benzoxazoles and Benzimidazoles Against C. albicans”, First Italian-Swiss Meeting on Medicinal Chemistry, September 23-26, 1997, Torino, Italy

89. SENER, E., OREN, I., TEMIZ-ARPACI, O., BINGOL, K. K., YALCIN, I., QSARs of Some Novel Antibacterial Benzoxazoles, Benzimidazoles, Benzothiazoles and Oxazolo(4,5-b)pyridines Against S. aureus., 1999 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 25-30 July 1999.

90. YALCIN, I., OREN, I., TEMIZ-ARPACI, O., TEKINER, B., SENER, E., QSARs of Some Novel Antifungal Active Isosteric Heterocyclics, 7th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 86, p.165, 08-11 September 1999.

91. YALCIN, I., TEKINER, B., OREN, İ., SENER, E., TEMIZ-ARPACI, O., ALTANLAR, N., Synthesis and Antimicrobial Activity of Some Novel 2,6,7-Trisubstituted-2(H)-3,4-dihidro-1,4-benzoxazine Derivatives., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract P-09, 22-24 September 1999.

92. SENER, E., ARPACI, O. T., OREN, I., BINGOL, K. K., YALCIN, I., The QSAR Analysis of Some Novel 2-p-Substituted-phenyl-5-Substitutedcarbonylaminobenzoxazoles Against a Gram-Negative Rod., 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey., Abstracts P-147 p. 282, 27-29 June 2000.

93. SENER, E., OREN, I., ARPACI-TEMIZ, O., YALIIN, I.; “3-D QSAR of Some Antifungal Active Heterocyclic Compounds Using the CoMSIA Method” 13th European Symposium on Quantitative Structure-Activity Relationships, QSAR 2000 Düsseldorf, Germany, Abstracts P 53, 27 August-1 September 2000.

21

94. ARPACI-TEMIZ O., SENER, E., YALCIN, I.; TEKINER, B., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2,5-Disubstitutedbenzoxazole Derivatives” 3rd International Symposium on Pharmaceutical Sciences, Istanbul, Turkey, Abstracts p. 193, 17-19 September 2001.

95. AKI-SENER, E, OREN, I., TEMİZ-ARPACI, O., YALCIN; I., “3-D QSAR of Some Antifungal Active Heterocyclic Compounds Using the CoMSIA Method” 13th European Symposium on Quantitative Structure-Activity Relationships, QSAR 2000 Düsseldorf, Germany, Abstracts P 53, 27 August-1 September 2000.

96. YALCIN, I., AKI-SENER, E., YILDIZ-OREN, I., TEMIZ-ARPACI, O., KOCAGOZ, T., YURDAKUL; P., “A New Class of Eukaryotic DNA Topoisomerase II Inhibitors”, XVIIth International Symposium on Medicinal Chemistry, Barselona, İspanya, Abstract page 512, 01-05 September 2002.

97. AKI-SENER, E., YALCIN, I., YILDIZ-OREN, I., TEMIZ-ARPACI, O., TEKINER,B., “3D-QSAR of Some Antibacterial Active Heterocyclics Using The CoMFA Method” Euro QSAR 2002, Bournemouth, Abstracts 098, 8-13 September 2002.

98. YILDIZ-OREN, I., TEKINER, B., TEMIZ-ARPACI, O., YALCIN, I., AKI-SENER; E.,“DTF Calculations of Some Antimicrobial Active 1,4-Benzoxazine-3-on Derivatives”, 1st International Meeting on Medicinal and Pharmaceutical Chemistry, Ankara, Abstract page 123, 25-28 September 2002.

99. TEKINER, B., TEMIZ-ARPACI, O., YILDIZ-OREN, I., YALCIN, I., AKI-SENER, E., “QSARs of some novel antifungal 5-substituted-2-(p-substitutedbenzyl)benzoxazoles against C. krusei ” 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 320, 24-27 June 2003.

100. TEKINER, B., YALCIN, I., YILDIZ-OREN, I., TEMIZ-ARPACI, O., AKI-SENER, E., ALTANLAR; N., “ Synthesis and antimicrobial activity of some 2,5-disubstitutedbenzoxazole derivatives against P. Aeruginosa” , 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 321, 24-27 June 2003.

101. YILDIZ-OREN, I., TEMIZ-ARPACI, O., TEKINER, B., AKI-SENER, E., YALCIN, I., “3-D QSAR of some microbiological active 2,5-disubstituted-benzoxazoles against S. Aureus using the CoMFA method” , 7thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 325, 24-27 June 2003.

102. AKI-SENER, E., YALCIN, I., YILDIZ-OREN, I., TEMIZ-ARPACI; “3D-QSAR of Some Antifungal Active Benzoxazoles, Benzimidazoles, Benzothiazoles and Oxazolopyridines Using the CoMFA Method”, Bioactive Discovery in the New Millennium, Lorne, Victoria, Australia, Abstract P53, 05-09 February 2003.

103. YILDIZ, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YALCIN, I., AKI-SENER, E., ZAFER, B., “CoMFA and CoMSIA studies of microbiologically active 5-(substituted-carbonylamino)-2-benzylbenzoxazoles” 4thInternational Symposium on Pharmaceutical Chemistry, Istanbul, Abstracts P-128 17-19 September 2003.

104. YILDIZ-OREN, I., TEKINER-GULBAS, TEMIZ-ARPACI, O., YALCIN, I., AKI-SENER, E., ALTANLAR; N. “ Synthesis and antimycotic activity of some new 2-benzyl-5-substituted carboxamidobenzoxazoles against Candida species”

22

Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, Krakow, Poland, Abstract P68, 15-18 October 2003.

105. TEMIZ-ARPACI, ALPER,S., YILDIZ-OREN, I., AKI-SENER, YALCIN, I., ALTANLAR, N., “ Synthesis and antimicrobial activity of some new 1,4-benzoxazine-3-one derivatives” Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, Krakow, Poland, Abstract P69, 15-18 October 2003.

106. YALCIN, I., AKI-SENER, E., YILDIZ, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B.,“Lead Optimization of some fused isosteric heterocyclic compounds as topoisomerase II inhibitors” Fifth AFMC International Medicinal Chemistry Symposium AIMECS 03, Kyoto, Japan, Abstract B-74, 14-17 October 2003.

107. YILDIZ, I., TEMIZ-ARPACI, ZAFER, B., TEKINER-GULBAS, ALPER, S., AKI-SENER, E., YALCIN, PINAR, A., YURDAKUL, P., ACAN , L., “Pharmacophore analysis of some ısosteric fused heterocyclics as topoisomerase II inhibitors” The 15th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, İstanbul, Turkey, Abstract B-18, 05-10 September 2004.

108. TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., TEKINER-GULBAS, B., ALPER, S., ZAFER, B., OKSUZOGLU, E., DIRIL, N., “ 2D-QSAR studies of some benzoxazoles and benzimidazoles” The 15th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, Istanbul, Turkey, Abstract B-19, 05-10 September 2004.

109. YILDIZ, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., ERTAN, T., AKI-SENER, E., YALCIN, I., “COMFA 3D-QSAR Studies on benzazole derivatives as eukaryotic topoisomerase II inhibitors” Joint Meeting on Medicinal Chemistry, Vienna, Austria, June 20-23, 2005 Scientia Pharmaceutica Supplement 1. 73(2) S234, 2005.

110. TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YILDIZ, I., AKI-SENER, E., YALCIN, I., ALTANLAR; N., “Synthesis and antifungal activity of some new 5-ethylsulphonyl-2-substitutedbenzoxazoles” Joint Meeting on Medicinal Chemistry, Vienna, Austria, June 20-23, 2005 Scientia Pharmaceutica Supplement 1. 73(2) S235, 2005.

111. ERTAN, T., YILDIZ, I., BOLELLI, K., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., ABBASOGLU; U., “Synthesis and antibacterial activity of some 4-substituted-N-(2-hydroxy-5(or 6)-nitrophenyl)benzamide derivatives” International Symposium on Medicinal Chemistry Research and Development Kusadasi, Turkey, Abstract P81, September 28-October 1, 2005,.

112. ALPER-HAYTA S., YILDIZ, I., AKI-SENER E., TEMİZ-ARPACI O., YALCİN I., “ QSAR of some antimicrobial 1,4-benzoxazine-3-one derivatives against C. krusei”, 8thInternational Symposium on Pharmaceutical Science, Ankara, Abstracts page 307, P-189, 13-16 June 2006.

113. YILDIZ, I., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., “3D-QSAR CoMSIA Study on Heterocyclic Topoisomerase II Inhibitors”, The 16th European Symposium on Quantitative Structure-Activity

23

Relationships & Molecular Modelling, Mediterranean Sea, Italy, Abstract page 223, 10-17 September 2006.

114. BOLELLI, K., YALCIN, I., ERTAN, T., KAYNAK-ONURDAG, F., YILDIZ, I., TEMIZ-ARPACI, I., AKI-SENER, E., ABBASOGLU, U., "Synhtesis, Structure Elucidation and Microbiological Activity of Some New 2-[4-(4-Substitutedbenzamido)phenyl]-benzothiazole Derivatives", Abst. P-61, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

115. ALPER-HAYTA, S., ARISOY, M., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., KAYNAK-ONURDAG, F., "Synthesis and Antimicrobial Activity of Some New N-(2-Substitutedbenzoxazol-5-yl)-2-benzofurancarboxamides", Abst. P-11, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

116. ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel 2-(p-Substitutedbenzyl)-5-(2-substitutedacetamido)benzoxazole Derivatives", Abst. P-24, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.

117. ALPER-HAYTA, S., YILDIZ, I., TEMIZ-ARPACI, O., AKI-SENER, E., YALCIN, I., “Free-Wilson Study on some microbiologically active benzazoles”, CMPTI-2007,Moscow, Russia, Abstract PO4, Sept. 01-05, 2007.

118. ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel N-(2-Substitutedbenzoxazol-5-yl)-2-(4-substitutedpiperazin-1-yl)acetamides", Abst. PC-29, 6th AFMC International Medicinal Chemistry Symposium (AIMECS 07), Istanbul-TURKEY, July 08-11, 2007.

119. 1.TEMIZ-ARPACI, O., ARISOY, M., KAYNAK-ONURDAG, F., YILDIZ, I., AKI, E., YALCIN, I., ABBASOGLU, U., “Synthesis and antimicrobial activity of some novel N-[2-p-substitutedbenzyl/phenyl-5-benzoxazolyl)]-2-morpholinoacetamides”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P63)

120. YILDIZ, I., ERTAN, T., BOLELLİ, K., TEMİZ-ARPACI, O., YALCIN, I., AKI, E., “ Molecular modeling studies on some benzoxazoles as eukaryotic DNA Topoisomerase II inhibitors”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P135).

121. 1- YILDIZ, İ., ATEİ, S., YILMAZ, S., FOTO, E., ERTAN-BOLELLİ, T., BOLELLİ, K., DİRİL, N., AKI, E., YALCIN. İ., “Three-Dimensional Common-Feature Hypotheses on Benzoxazine Derivatives as Topoisomerase I Inhibitors”, 18th International Conference on Organic Synthesis, Bergen, Norway, August 1-6, 2010, P:377.

122. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

24

123. TEMEL, E., BÜYÜKGÜNGÖR, O., CEYLAN, B., YILMAZ, S., YILDIZ, I., YALÇIN, I., AKI, E., “(E)-2-(4’-Klorofenil)-5(2’’-hidroksibenzilidenamino) benzoksazol Bileşiğinin Sentezi, Antimikrobiyal Etki Çalışması ve Moleküler Özelliklerinin Tek Kristal X-Işını Kırınımı Metodu ve Kuramsal Yöntemle İncelenmesi”, SP-017, Sayfa 180, Erzurum, Türkiye, 18-22 Mayıs 2011.

124. İLKAY YILDIZ, SERAP YILMAZ, SANAZ ATAEI, ESIN AKI, İSMAIL YALÇIN.Pharmacophore Analysis of Some Aromathecins as Topoisomerase I Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-36: p63.

125. KAYHAN BOLELLI, SERAP YILMAZ, İSMAIL YALÇIN, İLKAY YILDIZ, ESIN AKI, QSAR Analysis of Some 2-Substituted Benzothiazoles as Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus, NTCA-2011, 08-11 October 2011, Antalya PP-37: p64.

126. SERAP YILMAZ, İLKAY YILDIZ, ESIN AKI, İSMAIL YALÇIN.3D Pharmacophore Modelling of Some Fused Heterocyclic compounds as Topoisomerase II Inhibitor, NTCA-2011, 08-11 October 2011, Antalya PP-38: p65.

127. TUGBA ERTAN-BOLELLI, İLKAY YILDIZ, SELDA ÖZGEN, ESIN AKI, İSMAIL YALÇIN. QSAR Analysis of Some Novel 2-(p-Substitutedphenyl/benzyl)-5-(p-substitutedbenzensulfonamido) benzoxazoles against Mycobacterium tuberculosis isolate, NTCA-2011, 08-11 October 2011, Antalya PP-39: p66.

128. BOLELLİ, K., ERTAN-BOLELLI, T., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-[4-(4-Sübstitüebenzamido)fenil]benzotiyazol Türevlerinin 1H-NMR Spektroskopi Çalışmaları”, P-210, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

129. YILMAZ, S., YALCIN, I., AKI, E., YILDIZ, I., “Bazı Yeni 2-Benzotiyazol Türevlerinin 1H-Nükleer Manyetik Rezonans Spektrum Analizleri ile Yapılarının Aydınlatılması”, P-212, Uluslararası katılımlı XII. Ulusal Spektroskopi Kongresi, Antalya, Türkiye, 18-22 Mayıs 2011.

130. YILDIZ, I., ERTAN, T., BOLELLİ, K., TEMİZ-ARPACI, O., YALCIN, I., AKI, E., “ Molecular modeling studies on some benzoxazoles as eukaryotic DNA Topoisomerase II inhibitors”, 4th central European conference chemistry towards biology, Dobogo’ko’’, Hungary, Sept. 8-11, 2008 (Abstract P135).

131. YILDIZ, I., ATAEI, S., YILMAZ, S., AKI, E., YALCIN, I. “Study on molecular modeling of some topoisomerase I inhibitors” P-19, 11th International Nutrition&Diagnostics Conference INDC 2011, Brno, Czech Republic, August 28-31, 2011.

132. TUGBA ERTAN-BOLELLI, İLKAY YILDIZ, SELDA ÖZGEN, ESIN AKI, ISMAIL YALCIN. Docking Studies of Enoyl-ACP Reductase Enzyme Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO98:p161.

133. KAYHAN BOLELLI, TUGBA ERTAN-BOLELLI, OZUM OZTURK, ILKAY YILDIZ, ESIN AKI, ISMAIL YALCIN. Docking Studies of Some Fused Heterocyclic Compounds into HIV-1 Reverse Transcriptase Enzyme, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO95:p158.

25

134. ESIN AKI, TUGBA TASKIN, ISMAIL YALCIN, YAMAN MUSDAL, YASEMIN AKSOY, SERAP YILMAZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, İLKAY YILDIZ. Computational Drug Design Studies of Some new GST Inhibitory Active 2-Substituted Benzoxazoles and Benzothiazoles, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO93:p156

135. KAYHAN BOLELLI, SERAP YILMAZ, ILKAY YILDIZ, ESIN AKI, ISMAIL YALCIN. Common Feature Pharmacophore Generation of Bacterial AdeABC Efflux Pump Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO78:p141.

136. SERAP YILMAZ, SANAZ ATAEI, ILKAY YILDIZ, ESIN AKI, ISMAIL YALCIN. Pharmacophore Modelling of Some Fused Heterocyclic Compounds as HIV-1 Reverse Transcriptase Inhibitors, EuroQSAR Knowledge Enabled Ligand Design August 26-30, 2012 Vienna, Austria, PO83:p146.

137. SANAZ ATAEI, SERAP YILMAZ, ILKAY YILDIZ, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ESIN AKI-YALCIN, ISMAIL YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT006: p182), 3-5 July 2013.

138. OZUM OZTURK, ESIN AKI-YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, ILKAY YILDIZ, ISMAIL YALCIN. Common Feature Pharmacophore Generation of DNA Topoisomerase II Enzyme Inhibitors, 49th International Conference on Medicinal Chemistry (RICT-49), The Conference Center Nice Acropolis, Nice, France, HT094: p268, 3-5 July 2013.

139. SERAP YILMAZ, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, ILKAY YILDIZ, ESIN AKI-YALCIN. Molecular Modeling and Docking Studies of AcrB Trimeric Multidrug Efflux Pumps, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P11: p63.

140. OZUM OZTURK, ESIN AKI-YALÇIN, TUĞBA ERTAN-BOLELLI, KAYHAN BOLELLI, SERAP YILMAZ, İLKAY YILDIZ, İSMAIL YALÇIN. Docking Studies of Human Topoisomerase II Enzyme Inhibitors, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P12: p64.

141. KAYHAN BOLELLI, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, OZUM OZTURK, ILKAY YILDIZ, ESIN AKI-YALCIN. Docking Studies of Glutathion S-Transferase (GST) Inhibitors, 1st International BAU-Drug Design Symposium 2013, 21-23 March 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, P13: p65.

142. J.B. BHAGYASREE, HEMA TRESA VARGHESE, C. YOHANNAN PANICKER, JADU SAMUEL, CHRISTIAN VAN ALSENOY, KAYHAN BOLELLI, ILKAY YILDIZ, ESIN AKI. Vibrational spectroscopic (FT-IR, FT-Raman, 1H NMR and UV) investigations and computational study of 5-nitro-2-(4-nitrobenzyl) benzoxazole, 2st International Conference on New Trends in

26

Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, PP-26: p54, 25-28 October 2013.

143. KAYHAN BOLELLI, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, SERAP YILMAZ, OZUM OZTURK, YAMAN MUSDAL, ILKAY YILDIZ AND ESIN AKI-YALCIN. Molecular Docking Studies of Glutathion S-Transferase Inhibitors, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-03: p62, 15-18 October 2013.

144. SERAP YILMAZ, ISMAIL YALCIN, TUGBA ERTAN-BOLELLI, KAYHAN BOLELLI, OZUM OZTURK, SANAZ ATAEI, ILKAY YILDIZ, AND ESIN AKI-YALCIN. Molecular Docking Studies on AcrB Trimeric Multidrug Efflux Pumps of Escherichia coli, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-04: p63, 15-18 October 2013.

145. TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, SELDA OZGEN, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, OZUM OZTURK, ESIN AKI-YALCIN, AND ISMAIL YALCIN. Molecular Docking Studies on Enoyl-ACP Reductase Enzyme, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, P1-05: p63, 15-18 October 2013.

146. KAYHAN BOLELLI, TUĞBA ERTAN-BOLELLI, YAMAN MUSDAL, SERAP YILMAZ, OZUM OZTURK, YASEMIN AKSOY, ILKAY YILDIZ, ESIN AKI, ISMAIL YALCIN. Docking Studies on Glutathione S-Transferase P1-1 Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-03: p66, 8-12 October 2013.

147. TUGBA ERTAN-BOLELLI, ILKAY YILDIZ, KAYHAN BOLELLI, SERAP YILMAZ, SANAZ ATAEI, OZUM OZTURK, SELDA OZGEN, ESIN AKI, ISMAIL YALCIN. Molecular Docking Studies on Dihydropteroate Synthase Enzyme, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, PO-C-09: p72, 8-12 October 2013.